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Iron deficiency is the most common micronutrient deficiency worldwide.  Iron is essential for the 
development of multiple organ systems, most especially the developing brain.  Iron deficiency, 
particularly during sensitive periods of brain development, such as in early childhood, is associated with 
long lasting adverse consequences for cognition, motor function and behaviour.  Little consideration 
has been given to iron deficiency in newborn infants and its potential health consequences.  Fetal iron 
accretion is compromised by pregnancy complications such as preterm birth and gestational diabetes 
mellitus, and our work has identified an increased risk of low iron stores at birth from maternal lifestyle 
factors such as smoking and obesity.  Early-life events, including Caesarean section delivery, further 
add to the cumulative risk of neonatal iron deficiency, which can persist throughout infancy into early 
childhood.  While investigations into the long-term neurological consequences of neonatal iron 
deficiency are limited, there is evidence of poorer memory, motor function and language ability in 
children born iron deficient.  Recently, we also identified significant behavioural consequences of 
neonatal deficiency persisting from 2 to 5 years of age, with effects particularly apparent in ‘high-risk’ 
children born to obese or smoking mothers or delivered by Caesarean section.  Interventions targeting 
the fetal/neonatal period could, therefore, represent a key opportunity for the prevention of iron 
deficiency and its associated long-term health consequences.  A dual approach is required, comprising 
public health strategies targeting prevention, to improve health in women of reproductive age, and the 
development of screening strategies for the early detection of iron deficiency in newborn infants. 
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Iron deficiency, characterised by a reduction or depletion of the body’s iron stores, is the most common 
micronutrient deficiency in the world, affecting almost 2 billion people (McLean et al. 2009).  Women 
of reproductive age and young children are especially vulnerable, given the increased demands for iron 
during these periods of rapid growth and development (McLean et al. 2009; Domellof et al. 2014).  Iron 
is critical to the development of multiple organ systems, but most especially the developing brain.  Iron 
deficiency, particularly during  periods of rapid brain development, such as in early childhood, can have 
catastrophic consequences, with long lasting adverse effects on cognition, motor function and behaviour 
widely reported (Lozoff et al. 2006; Georgieff 2011). 
The late fetal and neonatal period is characterised by rapid and critical brain development; however, 
despite this, little consideration has been given to iron deficiency in newborn infants and its potential 
health consequences.  Newborn infants are at an increased risk of iron deficiency, as iron transfer to the 
growing fetus in utero is compromised by a number of maternal and pregnancy-related factors (Rao and 
Georgieff 2007).  Furthermore, low iron stores and iron deficiency at birth have been shown to 
predispose infants to iron deficiency later in infancy and early childhood (Georgieff et al. 2002; Hay et 
al. 2007; Akkermans et al. 2016). 
Here we provide an in-depth review of iron deficiency in the neonatal period, outlining the importance 
of iron to the developing brain, the acknowledged and unacknowledged risks for iron deficiency in 
newborn infants and, importantly, potential strategies for the prevention of neonatal iron deficiency and 
its associated long-term health consequences. 
IRON AND THE DEVELOPING BRAIN 
Iron is essential for the developing brain, given the key role it plays in fundamental neuronal processes, 
including neurotransmitter and energy metabolism and myelination (Lozoff and Georgieff 2006; Lynch 
et al. 2018).  Iron deficiency, particularly during sensitive periods of brain development, can disrupt 
these fundamental processes, as summarised in Table 1, resulting in adverse neurological consequences 
that often remain even after correction of the deficiency (Unger et al. 2012; Lynch et al. 2018).  Brain 
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development during the fetal and neonatal period is one such period of sensitivity, making newborn 
infants especially vulnerable to the neurological consequences of iron deficiency.  In-depth, extensive 
reviews of the underlying neurobiological effects of neonatal iron deficiency are available elsewhere 
(Lozoff and Georgieff 2006; Beard 2008; Georgieff 2011; Lynch et al. 2018). 
Neurological consequences of neonatal iron deficiency 
Despite the critical role of iron in the developing brain, investigations into the neurological 
consequences of iron deficiency in newborn human infants have been limited, often constrained by 
inadequate sample sizes and short-term neurological follow-up.  To date, abnormalities in the auditory 
neural pathway after birth were reported in term and preterm infants with cord ferritin concentrations 
<76 µg/L (Amin et al. 2010; Amin et al. 2013; Choudhury et al. 2015; ElAlfy et al. 2018), while reduced 
haemoglobin at birth, reflective of anaemia, the end-stage of iron deficiency, was associated with altered 
neonatal temperament in the first week of life (Wachs et al. 2005).  Infants born to mothers with 
gestational and pre-gestational diabetes with cord ferritin ≤34 µg/L, a threshold the authors calculated 
to reflect brain iron depletion, also had poorer recognition memory at ~15 days old (Siddappa et al. 
2004).  Furthermore, iron deficiency at birth that persisted into infancy was associated with poorer 
emotional reactivity and motor development at 9 months (Armony-Sivan et al. 2016; Santos et al. 
2018). 
In the first study with long-term follow-up, Tamura et al. (2002) observed poorer language ability, fine 
motor skills and tractability (ability to obey rules/behaviour) in 5-year-olds born with cord ferritin in 
the lowest quartile, corresponding to ferritin concentrations <76 µg/L.  Infants with low iron stores at 
birth born to mothers with diabetes also had long-term impairments in recall memory and psychomotor 
development into early childhood (Siddappa et al. 2004; DeBoer et al. 2005; Riggins et al. 2009).  
Contrastingly, iron status at birth was not associated with cognitive outcomes at 1 year of age in a 
prospective cohort in Benin (Mireku et al. 2016).  Recently, in our large maternal-infant birth cohort in 
Ireland, we identified significant behavioural consequences, measured using the Child Behaviour 
Checklist, of neonatal iron deficiency persisting from 2 to 5 years of age, with effects particularly 
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apparent in ‘high-risk’ children born to obese or smoking mothers or delivered by Caesarean section 
(observations under review). 
RISK FACTORS FOR NEONATAL IRON DEFICIENCY 
The total body iron content of term-born infants is ~75 mg/kg bodyweight, with the majority of this 
(70-80%) in red blood cells as haemoglobin.  The remainder of the iron is incorporated into iron-
containing proteins, such as myoglobin and cytochromes, or kept as storage iron, in the form of ferritin 
and hemosiderin (Widdowson 1974; Dallman et al. 1980).  However, this body iron content is highly 
variable as both modifiable and non-modifiable risk factors can affect fetal iron accretion, predisposing 
newborn infants to iron deficiency at birth and later in infancy (Hay et al. 2007; Rao and Georgieff 
2007).  These factors range from the widely acknowledged risks of maternal iron deficiency and 
prematurity, to the more unacknowledged and recently emerged risks of maternal obesity and delivery 
by Caesarean section.  Given that many of these risk factors often occur concurrently, the potential 
cumulative effect on neonatal iron status is considerable. 
Maternal iron status 
Pregnant women are especially vulnerable to iron deficiency and anaemia, as ~1000 mg of iron must 
be acquired during pregnancy to support feto-placental development and preserve maternal iron balance 
(McLean et al. 2009; Fisher and Nemeth 2017).  Sufficiently large iron stores at the onset of pregnancy, 
in addition to a diet abundant in bioavailable iron, are required to meet these increased requirements 
and avoid the development of iron deficiency (Lynch et al. 2018).  However, this is challenging: 
maternal iron deficiency affects 10-33% of pregnancies in Europe, with the highest rates observed in 
women during the third trimester (Milman et al. 2017).  Worryingly, recent data also suggests that poor 
maternal iron status, particularly in the third trimester, may be associated with adverse offspring 
neurological development (Janbek et al. 2019). 
Infants born to mothers with iron deficiency during pregnancy have reduced cord ferritin concentrations 
at birth, with maternal ferritin concentrations of 12-13.6 µg/L suggested as thresholds below which fetal 
iron accretion is affected (Gaspar et al. 1993; Hokama et al. 1996; Sweet et al. 2001; Jaime-Perez et al. 
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2005; Shao et al. 2012; Lee et al. 2016).  Infants born to mothers with mild/moderate iron deficiency 
anaemia (haemoglobin <110 g/L) during pregnancy have reduced iron stores at birth (Hokama et al. 
1996; Emamghorashi and Heidari 2004), while severe maternal iron deficiency anaemia (haemoglobin 
<70 g/L) results in reduced cord haemoglobin concentrations, in addition to reduced iron stores (El-
Farrash et al. 2012; Basu et al. 2016).  Furthermore, infants born to anaemic mothers, but with adequate 
neonatal iron stores at birth, have an increased risk of iron deficiency and iron deficiency anaemia later 
in infancy (Colomer et al. 1990; Kilbride et al. 1999). 
Prematurity and low birth weight 
Two-thirds of an infant’s total body iron is accreted during the third trimester of pregnancy.  Infants 
born premature are deprived of this significant iron accretion, with preterm birth also often coupled 
with other pregnancy complications that further compromise neonatal iron status (Singla et al. 1985; 
Rao and Georgieff 2001).  Total body iron content, haemoglobin and ferritin concentrations are lower 
in preterm infants (Halliday et al. 1984; Singla et al. 1985; Lackmann et al. 1998), even in late-preterm 
infants born ≥34 weeks’ gestational age (Ozdemir et al. 2013; Yamada and Leone 2014).  Between 20% 
and 50% of preterm infants are either born iron deficient or will become deficient in early infancy (Amin 
et al. 2010; Berglund et al. 2010; Amin et al. 2012; Uijterschout et al. 2015; Akkermans et al. 2016), 
with rates of 80-85% reported in preterm infants exclusively breastfed or receiving inappropriate iron 
supplementation (Iwai et al. 1986; Hall et al. 1993). 
Apart from the considerable impact of preterm birth itself, postnatal factors can also alter the baseline 
iron status of preterm infants, leading to an increased risk of iron deficiency.  Postnatal iron 
requirements are increased in preterm infants to facilitate their high rate of postnatal ‘catch-up’ growth, 
doubling their birth weight in 1-2 months, and the earlier onset of erythropoiesis, occurring 1-3 months 
earlier than in term infants (Lundstrom et al. 1977; Rao and Georgieff 2001).  Phlebotomy blood losses, 
routine for infants admitted to the Neonatal Unit, can result in a substantial loss of iron, especially if 
uncompensated (Obladen et al. 1988; Domellof and Georgieff 2015; Akkermans et al. 2016), while 
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delayed or inappropriate iron supplementation is another significant risk for iron deficiency (Agostoni 
et al. 2010). 
Low birth weight infants, including term, preterm or small-for-gestational age infants with a birth 
weight <2500 g, are typically born with lower iron stores and have an even more rapid relative growth 
rate (Mukhopadhyay et al. 2012; Domellof et al. 2014).  Infants born with an extremely low birth weight 
of <1000 g are at the highest risk, as without an appropriate external iron source they may be in negative 
iron balance within the first month of life (Shaw 1982). 
Pregnancy complications 
Pregnancy complications characterised by uteroplacental vascular insufficiency and/or chronic 
hypoxia, such as that caused by gestational diabetes mellitus, hypertension and preeclampsia, can also 
impact neonatal iron status.  In response to hypoxia, iron is drawn from hepatic storage pools to support 
increased erythropoiesis, resulting in reduced ferritin concentrations and increased transferrin and 
transferrin receptor concentrations in infants born to mothers with such conditions (Chockalingam et 
al. 1987; Murata et al. 1989; Verner et al. 2007).  The iron status of infants born to mothers with 
gestational diabetes mellitus is further compounded if the infant is born macrosomic (Georgieff et al. 
1990; McLimore et al. 2013).  Worryingly, these conditions can also result in reduced iron content of 
the liver, heart and brain, with neonatal liver and brain tissue iron reduced by 60% and 40%, respectively 
in post-mortem studies of newborn infants born to mothers with uteroplacental insufficiency (Petry et 
al. 1992; Georgieff et al. 1995). 
Maternal smoking 
Maternal smoking during pregnancy can result in fetal hypoxia, due to increased vascular resistance 
and thus poorer blood flow in the umbilical and uterine arteries, caused mainly by carbon monoxide.  
In such hypoxic conditions, erythropoiesis is stimulated, resulting in increased haematocrit and 
haemoglobin concentrations in infants (Meberg et al. 1979; Varvarigou et al. 1994; Wojtyla et al. 2012).  
Reduced iron stores at birth have also been reported in infants born to smoking mothers (Sweet et al. 
2001; Chelchowska and Laskowska-Klita 2002; Hay et al. 2007).  In our maternal-infant birth cohort, 
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maternal smoking was identified as an independent risk factor for neonatal iron deficiency: 17% of 
infants born to smoking mothers had cord ferritin <76 µg/L compared to 7% of infants born to non-
smokers (McCarthy et al. 2017). 
Maternal obesity 
The highest rates of obesity in women of reproductive age in Europe are seen in the UK and Ireland; 
almost 1 in 5 women of reproductive age have a body mass index (BMI) >30 kg/m2 (Devlieger et al. 
2016).  This is concerning as obesity in women who enter pregnancy is associated with an increased 
risk of adverse pregnancy outcomes, including preeclampsia, gestational diabetes mellitus and delivery 
of macrosomic infants, with long-term consequences for both the mother and child (Poston et al. 2016).  
Maternal obesity is now also emerging as a risk factor for neonatal iron deficiency. 
A positive correlation between early pregnancy maternal BMI and cord serum transferrin receptors was 
first reported in a Norwegian cohort (Hay et al. 2007).  Subsequently, maternal obesity both pre- and 
during pregnancy has been associated with reduced transferrin saturation, iron and ferritin 
concentrations and increased transferrin receptors in newborn infants (Dao et al. 2013; Phillips et al. 
2014; Jones et al. 2016; McCarthy et al. 2017).  While the mechanism of action remains to be fully 
elucidated, the iron-regulatory hormone, hepcidin, has been suggested to a play a role (Dao et al. 2013).  
In healthy pregnancies, hepcidin is downregulated in the second and third trimester to allow an 
increased supply of iron into maternal circulation.  The low-grade, chronic pro-inflammatory state of 
obesity results in an overexpression of hepcidin, inhibiting intestinal iron absorption and the release of 
iron from hepatic stores (Dao et al. 2013).  Elevated hepcidin and inflammatory marker concentrations 
have been observed in obese pregnant women in some (Dao et al. 2013; Garcia-Valdes et al. 2015; 
Jones et al. 2016; Flynn et al. 2018), but not all studies (Phillips et al. 2014; Cao et al. 2016).  Moreover, 
a potential threshold effect of maternal obesity was recently suggested, with poorer maternal and 
neonatal iron status associated with class 2 maternal obesity (≥35 kg/m2) only (Dosch et al. 2016; Flynn 
et al. 2018). 
Mode of delivery 
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The obstetric mode of delivery is another often unacknowledged determinant of neonatal iron status.  
In a meta-analysis by Zhou et al. (2014), when compared to vaginal delivery, delivery by Caesarean 
section was associated with decreased haemoglobin, haematocrit and erythrocyte concentrations in both 
the peripheral and cord blood of term-born neonates.  More recently, we observed an independent 
adverse effect of delivery by Caesarean section on neonatal iron stores, with infants delivered by 
Caesarean section twice as likely to have iron deficiency at birth than those delivered vaginally 
(McCarthy et al. 2017).  This adverse effect of Caesarean deliveries is likely due to a shorter period of 
placental transfusion due to immediate cord clamping and a weaker placental transfusion force 
associated with reduced uterine/vaginal contraction, maternal hypotension and a lack of a gravitational 
effect (Yao et al. 1968; Pisacane 1996).  This is concerning, given the reported rise in Caesarean 
deliveries worldwide, with rates of 26-33% in the UK and Ireland (Boerma et al. 2018; Health Service 
Executive 2018). 
STRATEGIES FOR THE PREVENTION OF NEONATAL IRON DEFICIENCY 
Interventions targeting the fetal and neonatal period could represent a key opportunity for the prevention 
of neonatal iron deficiency and its associated consequences for neurological development and iron 
status later in infancy.  As many of the aforementioned risk factors for neonatal iron deficiency are 
modifiable, strategies aimed at the prevention of iron deficiency should be prioritised; although, 
screening strategies for early detection should also be considered, especially as prevention may not 
always be feasible. 
1. Improved health and lifestyle of women of reproductive age 
Interventions targeting the mother are the best way to prevent iron deficiency in newborn infants.  To 
prevent maternal iron deficiency and anaemia, and thus its associated consequences for neonatal iron 
status, the World Health Organization recommends an iron intake of 30-60 mg/day during pregnancy, 
with 60 mg recommended in regions with a high anaemia burden (World Health Organization 2016).  
Recommended intakes in Ireland and the UK are lower, at 15 and 14.8 mg/day respectively (Food Safety 
Authority of Ireland 1999; Scientific Advisory Committee on Nutrition 2010).  To achieve these intakes, 
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iron supplementation is widely used in low- and high-resource settings, with daily supplementation 
shown to reduce iron deficiency and iron deficiency anaemia in pregnant women at term (Pena-Rosas 
et al. 2015).  However, supplementation strategies are not without limitations, as compliance may be 
poor, particularly in low-resource settings, and care is required to avoid excessive intakes (Wessling-
Resnick 2017).  Moreover, the direct effect of maternal iron supplementation on neonatal iron status 
and other neonatal outcomes is yet to be determined (Domellof et al. 2014; Pena-Rosas et al. 2015). 
Public health strategies to improve overall maternal health and lifestyle are also urgently required.  For 
example, the prevention of obesity in women of reproductive age is now recognised as critical to the 
health of mothers and their offspring.  Strategies incorporating a life-course approach, targeting the 
prevention of obesity prior to conception are recommended (Hanson et al. 2017), particularly as recent 
diet and lifestyle interventions in obese pregnant women did not result in significant improvements in 
pregnancy outcomes (Dodd et al. 2014; Poston et al. 2015).  Community-based awareness initiatives, 
combined with government policies, as have been recently implemented in The Netherlands (Denktas 
et al. 2014), appear to be the most promising strategy thus far. 
2. Delayed clamping of the umbilical cord 
In the first minutes after birth, a newborn infant can receive a substantial blood transfusion from the 
placenta, with a 32% increase in blood volume observed in infants held below the uterus for 3 minutes 
after birth (Yao et al. 1969).  Delayed clamping of the umbilical cord, for 1-3 minutes after birth or 
after cord pulsations stop, will therefore result in a larger placental transfusion than if the cord was 
clamped immediately after birth. 
A delay in cord clamping is recommended for term neonates, delivered vaginally or by Caesarean 
section, in the provision of essential neonatal care (National Institute for Health and Care Excellence 
2014; World Health Organization 2014; Royal College of Obstetricians & Gynaecologists 2015).  
Delayed cord clamping results in increased neonatal haemoglobin and ferritin concentrations after birth, 
without an increased risk of adverse health outcomes in the mother or infant, aside from some reports 
of an increased risk of polycythaemia (Hutton and Hassan 2007; McDonald et al. 2013).  These 
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improvements in iron status and decreased risk of iron deficiency and anaemia last throughout early 
infancy (Andersson et al. 2011; Mercer et al. 2018), even to 8-12 months of age (Gyorkos et al. 2012; 
Kc et al. 2017).  Furthermore, increased brain myelination at 4 months (Mercer et al. 2018) and 
improved fine motor and social development at 4 years, but not 1 year (Andersson et al. 2014, 
Andersson et al. 2015), has been reported in infants randomised to delayed clamping. 
Preterm infants, particularly those requiring stabilisation or resuscitation, can sometimes be denied this 
important placental transfusion at birth.  However, delayed cord clamping is recommended for preterm 
infants, where possible (World Health Organization 2014), with recent efforts being made to better 
incorporate delayed cord clamping into the stabilisation procedures for preterm infants (Knol et al. 
2018).  Elevated ferritin and haemoglobin concentrations after birth, a reduction in blood transfusion 
need and a lower risk of intraventricular haemorrhage and necrotising enterocolitis have all been 
reported in preterm infants delivered with delayed clamping (Rabe et al. 2012; Ranjit et al. 2015; Kc et 
al. 2017).  More recently, umbilical cord milking, a method of actively stripping blood from the cord, 
has been suggested as an alternative to delayed clamping in preterm infants; however, further research 
is required, particularly with respect to the long-term effects of this method (Al-Wassia and Shah 2015; 
Safarulla 2017). 
Despite current recommendations and the strong evidence supporting the benefits of delayed clamping, 
significant variability in this practice remains (Winter et al. 2007; Devin and Larkin 2018). 
3. Tailored supplementation regimens in high-risk infants 
The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 
Committee on Nutrition have stated that general iron supplementation in breastfed or formula-fed term 
infants is not required (Domellof et al. 2014).  In contrast, the American Academy of Pediatrics 
recommend 1 mg/kg/day of iron supplements for term, breastfed infants from 4 months of age until the 
introduction of iron-containing complementary foods (Baker and Greer 2010).  While this 
recommendation has since been questioned (Hernell and Lonnerdal 2011), given that it was based on 
one study (Friel et al. 2003), it was devised in response to the significant variability in neonatal iron 
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stores, even amongst term infants.  This substantive variability should be taken into consideration by 
clinicians, as preventive iron supplementation may be necessary on an individual basis, particularly in 
‘high-risk’ term infants.  Although, the potential risks of iron supplementation, particularly for growth 
and immune function, must also be carefully considered (Iannotti et al. 2006; Cusick et al. 2018).  The 
establishment of a screening protocol or tool, identifying the infants most at risk, could aid clinicians in 
the development of such individualised supplementation regimens. 
Iron supplementation is recommended for preterm infants but extreme caution is warranted, as their 
underdeveloped antioxidant defence system can also place them at an increased risk of iron overload 
(Wessling-Resnick 2017).  To achieve the necessary iron balance, current recommendations for enteral 
iron intakes in preterm infants are 2-3 mg/kg/day from the age of 2-6 weeks until at least 6-12 months 
(Agostoni et al. 2010; Baker and Greer 2010).  While these recommendations, made in 2010, were 
based on a limited evidence basis, there remains limited appropriate evidence since then to formulate 
revised recommendations, particularly with respect to optimal supplementation doses and duration 
(McCarthy et al. 2019).  Therefore, these recommendations should continue to be implemented in 
clinical practice, but further consideration must be given to more tailored supplementation regimens for 
individual patients, informed by monitoring of iron status indices, including ferritin and haemoglobin, 
both during and after the infant’s hospital stay.  Although, this monitoring should be incorporated into 
routine blood tests as part of standard clinical care, where possible, to avoid additional phlebotomy 
losses in this vulnerable population group. 
4. Screening strategies for early detection 
As the prevention of neonatal iron deficiency is not always feasible, for example when deficiency is 
secondary to conditions such as prematurity, screening strategies to facilitate the early detection of iron 
deficiency in newborn infants are pertinent.  Early detection will enable prompt treatment, thus ensuring 
normal neurological development in at-risk individuals.  Currently, screening strategies are either non-
existent, target older infants or focus solely on anaemia screening, all of which present significant 
challenges to achieving early detection. 
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Iron status can be considered as a continuum, moving from iron depletion to deficiency to anaemia, 
with each stage reflected by changes in iron biomarker concentrations (Table 2).  As anaemia is the 
end-stage of iron deficiency, screening for anaemia, measuring haemoglobin, will prove ineffective in 
facilitating the early detection of neonatal iron deficiency and preventing its associated neurological 
consequences.  Furthermore, during periods of increased iron demands, iron will be prioritised to red 
blood cells, to support erythropoiesis, over all other organs, including the brain (Petry et al. 1992; 
Siddappa et al. 2004; Lozoff et al. 2008).  Therefore, the brain will become iron depleted prior to the 
appearance of anaemia, resulting in the observed long-term neurological consequences (Georgieff 
2017). 
Ideally, screening strategies should therefore incorporate biomarkers that more accurately reflect or 
measure the iron content or iron-dependent processes in the brain.  While research is ongoing into 
potential novel biomarkers that directly assess iron-dependent brain functions (Rao et al. 2018), a more 
feasible approach at this time may be to relate a current early-stage iron biomarker directly to iron-
dependent brain function.  Ferritin concentrations, reflective of body iron stores, have been suggested, 
as reduced cord ferritin concentrations at birth are associated with short- and long-term adverse 
neurological outcomes (Tamura et al. 2002; Siddappa et al. 2004).  However, further research is 
required to ascertain the most appropriate ferritin threshold for use in infants, as the thresholds used to 
date were estimated based on population biomarker distributions and calculations, rather than on their 
direct relation to a functional brain outcome.  Reticulocyte haemoglobin content, reflective of functional 
iron availability, has been recently suggested as another potential biomarker for the early detection of 
individuals at risk of brain iron deficiency, prior to the emergence of anaemia (Ennis et al. 2018).  The 
incorporation of validated biomarkers sensitive to iron-dependent brain dysfunction into a screening 
protocol or tool as part of standard neonatal care at birth could represent a significant step towards early 





Newborn infants are highly susceptible to iron deficiency, with fetal iron accretion compromised by a 
number of maternal and pregnancy-related factors.  As iron deficiency at birth is associated with long-
term consequences for neurological development and subsequent iron status, strategies aimed at 
reducing the risk of iron deficiency in newborn infants are of the utmost importance.  A dual approach, 
comprising public health and clinical strategies targeting prevention, and screening strategies for the 
early detection of iron deficiency in newborn infants is required.  Public health strategies to improve 
the overall health and nutritional status of women of reproductive age are becoming increasingly 
important, although the efficacy and feasibility of such strategies requires further investigation.  In 
clinical practice, delayed cord clamping should be employed for term and preterm births, when possible, 
while a more tailored, personalised approach towards infant supplementation, informed by iron status 
monitoring, should be considered, especially in the case of high-risk infants, such as those born 
premature or with a low birth weight.  Moreover, the development of biomarker-based screening 
strategies for the early detection of iron deficiency in newborn infants could represent an invaluable 
opportunity to prevent the long-term health consequences of neonatal iron deficiency, especially in 
high-risk individuals where prevention is often not feasible.  
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Table 1 Iron and neurotransmitter metabolism, energy metabolism and myelination in the developing brain 
Neurotransmitter Metabolism Energy Metabolism Myelination 
 Most direct effect of iron is thought to be on 
the synthesis of the monoamine 
neurotransmitters, dopamine, serotonin and 
norepinephrine (Lynch et al. 2018). 
Monoamine synthesis begins in mid-
gestation, until about 3 years of age. 
 Altered monoamine metabolism results in 
disturbed sleep cycles, motor control, 
memory and social-emotional development 
(Herlenius and Lagercrantz 2004; Beard 
2008). 
 Iron deficiency affects neuronal energy 
metabolic balance, especially in the 
hippocampus, the region responsible for 
recognition memory processing and other 
cognitive functions (Rao et al. 2003; Lozoff 
and Georgieff 2006). 
 Disrupted energy metabolism results in 
abnormal arborisation (branching) of 
dendrites and synapse formation, leading to 
long-lasting morphological changes (Tran et 
al. 2008). 
 Iron deficiency, particularly in the late fetal 
and early childhood period, results in 
hypomyelination, a decrease in the production 
and quality of myelin, the fatty acid sheath 
surrounding neurons (Beard et al. 2003; Ortiz 
et al. 2004). 
 Hypomyelination impacts all brain regions, 
but disturbances in the auditory and visual 
systems of infants have been most closely 
linked to impaired myelination (Algarin et al. 















Storage Iron      
Ferritin     Confounded by inflammation 
Transport Iron      
Iron Normal    Diurnal and prandial variation 
Transferrin Normal    Diurnal and prandial variation 
Transferrin saturation Normal    Diurnal and prandial variation 
Soluble transferrin receptor Normal   Normal Limited availability, assay issues 
Erythrocyte protoporphyrin Normal   Normal Lacks specificity for iron 
Functional Iron      
Mean corpuscular volume Normal Normal  Normal Lacks specificity for iron 
Haemoglobin Normal Normal  Normal Low specificity and sensitivity 
 
